Spicejet will conduct the trial of the IATA (International Air Transport Association) Travel Pass on flights from Mumbai to Malé, starting from August 23, 2021.
The travel pass will manage and verify the traveller’s Covid-19 status in line with the governments’ health and border requirements.
In addition, Spicehealth, the healthcare arm of Spicejet, has been onboarded by IATA as a lab partner for the Travel Pass trial.
According to an official report, Spicehealth has conducted more than 3.5 million RT-PCR tests since its launch in November 2020. Spicehealth laboratories are accredited by National Accreditation Board for Testing and Calibration Laboratories and the Indian Council of Medical Research.
They currently operate 21 labs and collection centres for RT-PCR and rapid antigen testing spread across 11 cities in India. Besides, the company also operates seven vaccination centres across five states.
Ajay Singh, chairman, and managing director, Spicejet, said:
“Spicejet is proud to collaborate with IATA to trial IATA’s Travel Pass initiative. Passenger safety and comfort has always been our top priority and the introduction of the Travel Pass will make the verification process absolutely simple and hassle-free, boost both passenger and government confidence and make international travel more efficient and secure.”
“I am happy that IATA has confirmed Spicehealth labs for the Travel Pass trial enabling it to securely share certified test and vaccination certificates with passengers that will be recognised by governments abroad.”
Nick Careen, IATA’s senior vice president for Operations, Safety, and Security said:
“Adding Spicejet to the growing list of airlines trialling IATA Travel Pass is another step towards demonstrating to governments how digital solutions can effectively manage both Covid-19 vaccine and test certificates for travel.
“IATA Travel Pass will simplify and enhance compliance with health requirements for SpiceJet’s passengers, facilitating a more seamless experience.”
